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Abstract
Decorin, a small leucine-rich proteoglycan harboring a dermatan sulfate chain at its N-terminus, is involved in regulating
matrix organization and cell signaling. Loss of the dermatan sulfate of decorin leads to an Ehlers-Danlos syndrome
characterized by delayed wound healing. Decorin-null (Dcn2/2) mice display a phenotype similar to that of EDS patients.
The fibrillar collagen phenotype of Dcn2/2 mice could be rescued in vitro by decorin but not with decorin lacking the
glycosaminoglycan chain. We utilized a 3D cell culture model to investigate the impact of the altered extracellular matrix on
Dcn2/2 fibroblasts. Using 2D gel electrophoresis followed by mass spectrometry, we identified vimentin as one of the
proteins that was differentially upregulated by the presence of decorin. We discovered that a decorin-deficient matrix leads
to abnormal nuclear morphology in the Dcn2/2 fibroblasts. This phenotype could be rescued by the decorin proteoglycan
but less efficiently by the decorin protein core. Decorin treatment led to a significant reduction of the a2b1 integrin at day 6
in Dcn2/2 fibroblasts, whereas the protein core had no effect on b1. Interestingly, only the decorin core induced mRNA
synthesis, phosphorylation and de novo synthesis of vimentin indicating that the proteoglycan decorin in the extracellular
matrix stabilizes the vimentin intermediate filament system. We could support these results in vivo, because the dermis of
wild-type mice have more vimentin and less b1 integrin compared to Dcn2/2. Furthermore, the a2b1 null fibroblasts also
showed a reduced amount of vimentin compared to wild-type. These data show for the first time that decorin has an
impact on the biology of a2b1 integrin and the vimentin intermediate filament system. Moreover, our findings provide
a mechanistic explanation for the reported defects in wound healing associated with the Dcn2/2 phenotype.
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Introduction
Decorin belongs to the small leucine-rich proteoglycans and is
covalently linked with a linear glycosaminoglycan (GAG) chain.
Depending on the tissue the GAG chain is either chondroitin or
dermatan sulfate (CS/DS). CS is composed of disaccharide repeats
of D-glucuronic acid (GlcA) and N-acetylgalactosamine (GalNAc).
The stereochemistry of the glycosidic linkage in CS is (bD-GlcA1’-
.39 bD-GalNAc1’-.49-). In DS the D-GlcA is epimerized to L-
iduronic acid (L-IdoA) with a glycosidic stereochemistry (aL-
IdoA1’-.39 bD-GalNAc1’-.49-). The function of decorin is
diverse and ranges from modulating collagen fibrillogenesis [1,2]
and matrix organization [3] to cell adhesion and migration [4].
Furthermore, decorin can act as a signaling molecule by binding to
receptors such as the epidermal growth factor receptor [5,6,7],
insulin-like growth factor receptor-1 [8,9], cMET/hepatocyte
growth factor receptors [10] or LDL receptor-related protein-1
(LRP1) [11]. In a contact allergy model the loss of decorin leads to
a reduced edema formation and to an increase in sydecan-1
expression [12]. Also, decorin is able to decrease the amount of
miR-21 and IL-10 and to stimulate the production of the
proinflammatory tumor suppressor PDCD4 [13]. In addition,
decorin can modulate transforming growth factor-b bioavailability
[14].
The importance of the GAG chain of decorin was shown in
EDS patients harboring mutations in the bGALT4 gene which
cause reduced enzymatic activity [15,16]. Patients’ skin fibroblasts
synthesized decorin partially without a GAG chain and the
remaining GAG chains displayed reduced epimerization [16].
More recently, a new form of EDS was described. These patients
exhibit only CS in the dermis due to the deficiency in the enzyme
dermatan-4 sulfotransferase (Chst15) [17]. The loss of DS leads to
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a cutis laxa condition characterized by reduced deposition of
collagen bundles in the dermis demonstrating the importance of
DS in the dermal architecture [18]. An animal model with
a genetic ablation of the dermatan C5 epimerase (EC 5.1.3.19)
leads to only 20% L-IdoA in DS in the skin which shows an
increased fibrillar diameter in the collagens [19]. The Dcn2/2
mice display a skin EDS phenotype showing fibrils with an altered
fibrillar diameter and abnormal supramolecular organization
resulting in skin fragility [20] and delayed wound healing [21].
Using a 3D cell culture model of Dcn2/2 fibroblasts the fibrillar
collagen phenotype was rescued by addition of decorin [22].
Interestingly, addition or viral expression of GAG-free decorin in
Dcn2/2 cells induce a phenotype similar to that seen in the
dermatan C5 epimerase2/2 mice [19] with an increased fibrillar
diameter [23] indicating that the decorin GAG chain is important
for regulating both shape and size of the collagen I fibrils. These
examples show that not only GAGs but also the amount of
epimerization of the GAG is important for matrix organization
and dermal wound healing.
The collagen binding integrins a1b1, a2b1 and a11b1 are
expressed on fibroblasts [24]. On a cellular level, Dcn2/2
fibroblasts show an increase in b1 integrin expression as compared
to wild-type lung fibroblasts, and this leads to an enhanced
adhesion to collagenous matrices [4]. Fibroblasts synthesizing their
own 3D matrix use a5b1 integrin for adhesion, the major receptor
for fibronectin [25]. Previously, it has been shown that decorin
binding to b1 integrin requires the GAG chain [26]. Furthermore,
only a2b1 but not a1b1 integrin is modulated by the proteoglycan
decorin [27].
The expression pattern of intermediate filaments (IF) is cell and
tissue specific [28], and fibroblasts contain the IF vimentin [29].
Vimentin belongs to the type III cytoplasmic IF type and shows
a highly conserved secondary structure [30]. The IF system is
a highly dynamic structure regulated by an equilibrium between
subunits and polymers [31]. The IF vimentin is involved in the
regulation of cell adhesion to collagens [32,33]. In vitro studies
show that vimentin can interact with a2b1 integrin cytoplasmic
domains [34]. The main function of the IF vimentin is the
maintenance of the cell and tissue integrity, cell shape and
resistance to mechanical stress. Furthermore, it is involved in the
intracellular distribution and function of organelles [35,36].
Vimentin also contributes to the retrograde transport of Erk1/2
in injured neurons [37]. Vimentin2/2 mice undergo normal
embryonic development. The mice appeared to develop and
reproduce normally [38]. Vimentin-deficient fibroblasts display
a reduced mechanical stability and aberrant focal adhesions [39].
Challenging these mice in vivo by wounding, vimentin-deficiency
leads to a delay in wound healing due to reduced migration of
fibroblasts [40].
The aim of our study was to determine the impact of both
a Dcn2/2 matrix and a matrix deficient in the decorin dermatan
sulfate chain on the vimentin IF system in fibroblasts. We
discovered that the proteoglycan decorin is required for regulating
b1 integrin levels in Dcn2/2 fibroblast in order to stabilize the
vimentin IF system. The results obtained in the 3D cell culture
system were confirmed in vivo in the dermis of Dcn2/2 mice
compared to wild-type dermis. These results show that under
matrix synthesizing conditions decorin is necessary for the
vimentin IF system and that the mediating link is the a2b1
integrin. The present results provide a mechanistic explanation for
the increased adhesion of Dcn2/2 fibroblasts and the delay in
wound healing.
Materials and Methods
Decorin-null and Integrin a2-Null Mice
Dcn2/2 mice [20] were bred in the animal facility of the
Institute of Physiological Chemistry and Pathobiochemistry of the
University of Mu¨nster in accordance with the German Animal
Protection Act (May 25th 1998) and approved by LANUV, NRW,
Germany. Mice deficient for the integrin a2 subunit and
corresponding littermate controls were generated by heterozygous
matings as previously described [41]. Mice were sacrificed with
CO2 and all efforts were made to minimize suffering.
Materials
The following primary antibodies were used: vimentin (mono-
clonal rabbit anti-mouse, Epitomics, California), vimentin (mono-
clonal rabbit anti-mouse, BioVision, San Francisco), phosphory-
lated vimentin pSer72 (monoclonal rabbit anti-mouse, Epitomics,
California), type 1 collagen (rabbit anti-mouse, Acris, Herford,
Germany), Ki67 (Dako), decorin LF113 (rabbit anti-mouse) [42],
fibronectin (rabbit anti-mouse), polyclonal rabbit anti-mouse b1
integrin (Millipore) recognizing the cytosolic C-terminal domain,
LEAFTM b1 integrin blocking antibody (armenian hamster anti-
mouse, BioLegend, California), b1 integrin clone 9EG7 (BD
Pharmingen) against the active conformation of the b1 integrin
and a2 integrin (R&D), a5 integrin (polyclonal rabbit anti-mouse,
Millipore), P-Tyr/Ser/Thr (Stressgen, MI, USA). Secondary
antibodies were: Alexa 488 goat anti-rabbit, Alexa 488 goat
anti-mouse (Molecular Probes, Eugene, Oregon) and Cy3 donkey
anti-rat (Dianova) as well as donkey anti-rabbit IgG HRP (GE
Healthcare, UK), donkey anti-sheep/goat IgG HRP (Millipore)
and rabbit anti-mouse IgG HRP (Sigma). F-actin cytoskeleton was
visualized by Alexa 488 labeled phalloidin (Lonza, Walkersville).
DS was obtained by b-elimination from decorin derived from
human skin fibroblasts [16].
3D Cultures of Primary Fibroblasts
Skin fibroblasts were obtained from one-day-old Dcn2/2 mice
[20] or integrin a2
2/2 mice [40] and respective controls. Cells
were cultured in modified Eagle’s minimum essential medium
(MEM) with Earle’s salts and supplemented with 10% fetal calf
serum (Biochrom, Berlin, Germany), 2 mM glutamine and
100 U/ml penicillin–0.1 mg/ml streptomycin (PAA, Co¨lbe,
Germany). Cells were used for the subsequent experiments at
passage 3 as described [22,23]. Briefly, 200.000 cells/well were
seeded to confluence in a 24-well plate (Greiner, Frickenhausen,
Germany). After 24 h the medium was replaced with fresh
medium containing 1 mM L-ascorbic acid 2-phosphate (Sigma,
Deisenhofen, Germany) and the indicated additives. Additives like
skin fibroblast decorin (5 mg/ml) and decorin core (Life Cell) were
added to the medium. Cells were cultured for 3, 6 or 14 days and
medium containing the supplements and decorin or decorin core
was changed every other day.
2D Gel Electrophoresis and Peptide Mass Fingerprinting
Protein lysates were harvested from 12 well Dcn2/2 cultures at
3 day using rehydration buffer. The isoelectric focusing was
carried out with ZOOM IPGRunner Kit (Invitrogen) according to
the manufacturer’s instructions. Zoom Stripes with a pH 3–10
range were used overnight followed by SDS-gel electrophoresis
[43]. After colloidal Coomassie [44] staining all 3 samples were
evaluated. Spots were sent to the Centre for Molecular Medicine
Central Bioanalytics, Cologne, and analyzed by peptide mass
fingerprinting.
Decorin Affects Vimentin
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Immune Fluorescence Detection of the Intracellular
Filament System and Decorin
For immune fluorescence analysis cells were seeded in m-Slide
VI (ibidi, Martinsried, Germany). All the following procedures
were carried out directly in the m-Slides. At day 6, cells were fixed
with 0.5% paraformaldehyde/PBS for 10 min and permeabilized
with 1% Triton X-100 in PBS for 5 min. Nonspecific binding sites
were blocked with 3% BSA/PBS for 20 min. Immune fluores-
cence staining was performed for collagen type I, decorin,
vimentin, P-Ser72 vimentin, F-actin and Ki67 1:100 in 1%
BSA/PBS at 4uC overnight. After washing with PBS the primary
antibodies were detected with Alexa 488 goat anti-rabbit, Alexa
488 goat anti-mouse or Cy3 donkey anti-rat 1:1000 in 1% BSA/
PBS containing 1 mg/ml DAPI (Sigma, Deisenhofen, Germany)
for 1 h at room temperature. Fluorescence was monitored by
a Zeiss Axiovert 200 M microscope (Carl Zeiss AG, Jena,
Germany). 3D imaging through the complete matrix was done
with an OptiGrid Structured Light-System (Qioptiq LINOS Inc,
New York) and Volocity (Improvision/PerkinElmer, Waltham,
Massachusetts).
Quantification of Fluorescence Signals
To quantify the fluorescence signals in the 3D cultures control
slides were analyzed at different exposure times [45]. All images
were taken at the same exposure time with gain settings in the non
saturated range. Digital images of control, decorin treated and
decorin core-treated cells (for each condition n$10 per experi-
ment) were acquired with a Zeiss Axiovert 200 M microscope
(Carl Zeiss AG, Jena, Germany) [6]. 3D imaging through the
complete matrix was achieved with an OptiGrid Structured Light-
System (Qioptiq LINOS Inc, New York) and monitored with
Volocity (Improvision/PerkinElmer, Waltham, Massachusetts).
Coloured Z-axis layers were merged and re-converted to 8-bit
grayscale images without any further digital processing. Values
were calculated using ImageQuant (Molecular Dynamics). The
obtained volumes were normalized to the cell number of each
image indicated by DAPI staining of nuclei.
Production and Purification of Human Decorin
Decorin was purified under native conditions from conditioned
medium of human skin fibroblasts as described before [23,46].
Briefly, human decorin was purified via the glycosaminoglycan
chain using a weak ion-exchanger. 1 L conditioned media was
concentrated using a DEAE-Ceramid column (Pall Life Science,
Dreieich, Germany) and eluted with 1 M NaCl in 20 mM TRIS
buffer followed by HPLC-DEAE eluted with a discontinuous NaCl
gradient. The amount of purified proteoglycan decorin from 1 L
conditioned medium was 1–1.5 mg, containing about 50–55%
dermatan sulphate [16]. The purity of decorin was verified by
silver staining after SDS gel electrophoresis. Purification and
characterization of the biologically active human decorin protein-
core was described before [47]. Briefly, recombinant decorin
protein core was purified from conditioned media of a stably
transfected 293HEK EBNA cells via the N-terminal His x 6 Tag
using a nickel-chelating column. The proteoglycan decorin and
the decorin core were subsequently separated by anion-exchange
chromatography. Decorin, decorin core and different GAG
preparations were analysed for endotoxins with E-TOXATETM
kit according to the manufactures instructions (Sigma, Germany).
Minute quantities of endotoxins can cause the E-TOXATE
reagent to gel. We analyzed the samples at a 4 times higher
concentration than that used in the experiments. Decorin, decorin
core and the GAGs did not induce a gel formation indicating that
the samples contain no endotoxin or at concentration below the
limit of detection (0.05 endotoxin units).
Atomic Force Microscopy
Contact mode AFM on cells was performed as described before
[48]. In this study, cells were chemically stabilized by glutardial-
dehyde fixation (1% final concentration). Briefly, AFM measure-
ments were carried out in PBS (pH 7.4) using a MultiMode AFM
with Nanoscope III controller and software version 5.30sr3
(Digital Instruments, Santa Barbara, CA, USA). Silicon-nitride
tips on V-shaped gold-coated cantilevers were used (0.01 N/m,
MLCT, VEECO, Mannheim, Germany). Imaging of fixed cells
was performed at ambient temperature with forces around 1 nN at
1–3 scan lines per second (1–3 Hz) and 512*512 pixels resolution.
Images were processed using the software SPIP, version 3.3.9 by S.
Jorgensen (Lyngby, Denmark).
mRNA Extraction and Quantitative Real-time PCR
For gene expression analysis cells were seeded in 24-well plates
(Greiner, Frickenhausen, Germany). Total RNA was extracted
from cells at day 3, 6 and 14 using RNeasy Mini Kit (Qiagen,
Hilden, Germany). cDNA was synthesized from 2 mg of total RNA
using Omniscript RT Kit (Qiagen). mRNA levels of target genes
were quantified by Real-Time RT-PCR using an ABI PRISM
7500 Sequence Detector (Applied Biosystems) (core unit IZKF
Mu¨nster) and MESA GREEN (Eurogentec, Ko¨ln, Germany).
Amplification was performed in triplicate in a total volume of
25 ml. Raw data were normalized on geometric average of control
genes [49]. The primer pairs were designed to overlap intron/
exon borders and to minimize primer-dimers. Annealing temper-
ature was calculated to be identical for all primer pairs. Nucleotide
sequence of the primers used in this study: vimentin-F 59-
CTGTGTCCTCTGCCTCCTA-39; vimentin-R 59-
CCACTTTCCGTTCAAGGTCAAG-39; integrin beta 1-F 59-
CAA GAG GGC TGA AGA TTA CC-39; integrin beta 1-R 59-
GGC ATC ACA GTT TTA TCC A-39; actin-F 59-
GGGTGTGATGGTGGGAATGG-39; actin-R 59-
TGGCTGGGGTGTTGAAGGTC-39; GAPDH-F 59-ATT-
CAACGGCACAGTCAAG-39; GAPDH-R 59-TTCACACC-
CATCACAAACAT-39; ubiquitin c-F 59-GCCCAGTGTTAC-
CACCAAG-39; ubiquitin c-R 59-
CACCAAAGAACAAGCACAAG-39. F-forward primer, R-re-
verse primer.
Protein Extraction and Western Blotting
For protein analysis cells were seeded in 12-well plates (Greiner,
Frickenhausen, Germany). At day 3, 6 and 14 cells were lysed with
200 ml/well urea buffer (40 mM Tris, 7 M urea, 2 M thiourea
and 1% ASB-14 (Sigma, Deisenhofen, Germany)) for 10 min on
ice. Total protein lysates were dissolved in SDS sample buffer,
separated on 12% gels and transferred to PVDF membranes. After
blocking with 5% milk powder/TBS-Tween for 1 h the
membranes were incubated with antibodies against the target
proteins fibronectin, b1 integrin, a2 integrin, a5 integrin,
vimentin, P-Tyr/Ser/Thr and GAPDH 1:1000 in 2.5% milk-
powder/PBS at 4uC over night. After washing with TBS-Tween
the membranes were incubated with the secondary antibody (anti-
rabbit-HRP, Amersham; anti-goat-HRP, Millipore) for 1 h.
Proteins were visualized using ECL Western blotting detection
reagents (Pierce, Rockford, USA) and Fusion-SL 4.2 MP (PeqLab,
Erlangen, Germany). Grey-scale values were calculated using
ImageQuant (Molecular Dynamics) and target proteins were
related to GAPDH or total protein amount visualized by SDS-
PAGE and Coomassie staining.
Decorin Affects Vimentin
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Metabolic Labeling and Immune Precipitation
Dcn2/2 cells were seeded in 6-well plates and cultured for 6
days as described above. Cells were washed with PBS and 1 ml/
well cysteine/methionine-free MEM (GIBCO) containing 10%
FCS was added. After addition of 100 mCi/ml L-35S-Cysteine and
L-35S-Methionine cells were incubated over night at 37uC.
Matrices were washed trice with PBS and harvested in 500 ml/
well lysis buffer (150 mM NaCl, 25 mM Tris, 5 mM EDTA, 0.5%
NP40, proteinase-inhibitor, pH 7.4). Cell disruption was done at
220uC. Lysates were centrifuged (5 min, max rpm, 4uC) and pre-
cleared each with 10 ml rabbit serum for 30 min at 4uC. Metabolic
labeling was verified by determination of [35S] incooperation
under all three conditions. Protein A sepharose was equilibrated
with buffer (20 mM NaH2PO4, 150 mM NaCl, proteinase-
inhibitor, pH 8.0) and 10 ml of this suspension added to each
lysate. After incubation at 4uC for 30 min, lysates were centrifuged
for 1 min at 10.000 rpm. Vimentin antibody (BioVision) was
added to the supernatant in a 1:10 dilution and incubated
overnight at 4uC. Equilibrated protein A sepharose was blocked
with 2% BSA/PBS and then 50 ml were added to each lysate.
After incubation at 4uC for 2 h precipitates were centrifuged for
1 min at 10.000 rpm. The immune complex was washed thrice
with buffer I (400 mM NaCl, 25 mM Tris, 5 mM EDTA, 0.5%
NP40, proteinase-inhibitor) and one time with buffer II (125 mM
Tris, proteinase-inhibitor, pH 6.8). The immune precipitation of
vimentin was confirmed by determination of [35S]. 40 ml SDS
sample buffer (56, reduced) were added and samples were
separated in a SDS-PAGE (4.5–15%) and fixed for 10 min in 25%
methanol/7% acetic acid. After incubation in 1 M sodium-
salecylate for 1 h the gel was washed thrice with dH2O and
dehydrated in 20% ethanol/3% glycerine overnight. The gel was
dried and the fluorographs were developed at 280uC.
Measuring pH at the Cell Surface
The cell surface pH of Dcn2/2 cells was measured as previously
described for B16 melanoma cells [50]. Initially, cells were seeded
on collagen I and cultured for 24 h. The glycocalix was then
labeled with 12.5 mg/ml wheat germ agglutinin (WGA, Molecular
Probes) in HEPES-buffered Ringer solution [51]. pH was
measured ratiometrically using the Metafluor software (Visitron
Systems GmbH, Puchheim, Germany). Cells were continuously
superfused with prewarmed (37uC) Hepes-buffered Ringer solu-
tions of pH 7.2. The excitation wavelength for WGA alternated
between 440 nm and 490 nm while the emitted fluorescence
intensities were monitored at 510 nm using a Photometrics
camera (CoolSnapfx, Visitron Systems). A ratio was calculated
from the intensities measured at 440 and 490 nm. Thus, the
measurement was virtually independent of the amount of dye
excited in a given region of interest and represented the local
proton concentration. Fluorescence intensities were measured in
35 second intervals and corrected for background fluorescence by
subtracting background intensities of control regions placed right
next to the measured regions of interest. At the end of each
experiment, the pH measurements were calibrated applying the
nigericin/high [K+] method as published [50].
Blocking of ß1 Integrin
To analyse the effect of blocking the b1 integrin subunit, cells
were incubated with Low Endotoxin Azide Free (LEAFTM) b1
integrin blocking antibody (5 mg/ml) for 6 h at 37uC. Cells were
washed twice with PBS and harvested with urea containing lysis
buffer. Vimentin expression was analysed by Western blotting as
described above.
Results
The Loss of Decorin Affects Vimentin Expression in vitro
and in vivo
To investigate the effects of decorin and dermatan sulfate on cell
function, we used an in-vivo-like cell culture system consisting of
Dcn2/2 dermal fibroblasts synthesising their own collagen-rich
matrix and supplemented with decorin or decorin protein core.
Two-D protein screening followed by peptide mass fingerprinting
of Dcn2/2 fibroblasts treated with decorin showed that vimentin
was regulated differentially when compared to non-treated cells
(Figure S1). Immunofluorescence (data not shown) and Western
blot analysis of dermal extracts of adult Dcn2/2 and wild-type
mice showed that vimentin was significantly reduced by the
ablation of decorin (Figure 1A, B). We confirmed by qRT-PCR
that wild-type fibroblasts express significantly more vimentin than
Dcn2/2 fibroblasts when the cells are 3 days in culture and
therefore in a 2D environment (Figure S2). Surprisingly, treating
Dcn2/2 fibroblasts with decorin at this time point results in
a significant reduction of vimentin mRNA, supporting the idea,
those fibroblasts should be in a 3D environment (Figure S2).
To evaluate the screening and the in vivo results at a molecular
level, we analyzed matrix formation in cultures of Dcn2/2
fibroblast. Dcn2/2 fibroblasts were treated with either the
proteoglycan decorin or its core in the presence of ascorbate-2-
phosphate to generate altered collagen-rich matrices. To study the
influence of the GAG chain, the decorin protein core was used. At
day 3, 6 and 14, the Dcn2/2 fibroblasts inside their own matrix
were analysed by Western blotting for vimentin expression
(Figure 1C). We have previously shown that at day 6, the cells
already produce matrix molecules like collagen I, III and V and
deposit these molecules around the cells [22]. Here we found
a significant increase in vimentin caused by decorin treatment
(Figure 1D). Therefore, exogenous decorin can rescue the
vimentin IF system in the Dcn2/2 cultures. Interestingly,
treatment with the decorin core revealed also a significant increase
of vimentin but less effective as the decorin treatment.
Next, we visualised the vimentin IF system using immunoflu-
orescence microscopy on cells cultured on m-slides (Figure 2A).
Quantification of the fluorescence signal showed that added
decorin increased the amount of vimentin in the Dcn2/2
fibroblasts (Figure 2B), while the effects of the decorin protein
core were less dramatic. The analysis of (i) the actin expression by
qRT-PCR and (ii) the actin cytoskeleton by phalloidin staining or
atomic force microscopy showed no alterations in decorin treated
or untreated fibroblasts (Figure S3). Also when cultured in m-slides
Dcn2/2 fibroblasts produce their own collagen-rich matrix
(Figure 2D) and incorporate the proteoglycan decorin as well as
the decorin protein core (Figure 2C). Decorin synthesis by wild-
type fibroblasts and deposition into the matrix was clearly
detectable after 4–6 day (data not shown). Of note is the altered
organization of vimentin in Dcn2/2 fibroblasts compared to
cultures treated with decorin and its core.
Decorin-deficiency Influences the Nuclear Morphology in
Dcn2/2 Cells
In preliminary experiments we noticed that upon decorin
treatment, the nuclei of the Dcn2/2 fibroblasts actively producing
matrix were quite elongated as compared to controls. To
investigate this in more depth, we first cultured fibroblasts from
various genotypes for 6 days, labeled the nuclei with the
fluorescence dye DAPI and analyzed the cells by fluorescence
microscopy. 3D imaging through the complete matrix was done
with an OptiGrid Structured Light-System (Qioptiq LINOS Inc,
Decorin Affects Vimentin
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New York). Colored Z-axis layers were merged. Interestingly, the
nuclear morphology was different in the decorin and decorin core
treated 3D cultures as compared to untreated Dcn2/2 cells. Wild-
type fibroblasts displayed a round morphology different to the
ellipsoid form of the Dcn2/2 fibroblasts (Figure 3A). To quantify
these differences in the nuclear morphology, we determined the
morphology index [52] as a ratio of length to width for wild-type
and Dcn2/2 fibroblasts (Figure 3B). The wild-type form resulted
in a morphology index of 1 significantly different from the 1.5 of
Dcn2/2 fibroblasts. Exogenous addition of decorin leads to
significant changes in the index to 1, which is similar to the wild-
type. The treatment with decorin protein core also significantly
Figure 1. Detection of vimentin in vivo in Dcn2/2 and wild-type mouse skin and in vitro. (A) Western blot for vimentin (57 kDa) with two
different skin extracts of adult wild-type and Dcn2/2 mice (upper panel). Coomassie gel was used as loading control and shows the corresponding
protein extracts (lower panel). (B) Quantification of Western blots, where the vimentin signal was normalized to the Coomassie gel staining (n = 4; **,
p,0.01). (C) Dcn2/2 fibroblasts were cultured for 3, 6 and 14 days in the presence of ascorbate-2-phosphate and treated with decorin or decorin core
(core) and the respective controls. Protein extracts were immunoblotted with antibodies to detect vimentin. Coomassie gel was used as loading
control (lower panel, exemplary). (D) Quantification of vimentin protein expression at day 3, 6 and 14. Western blot signals were normalized to
Coomassie staining. Data represent 3 independent experiments and are expressed as mean 6 SD (*, p,0.05).
doi:10.1371/journal.pone.0050809.g001
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changed the index but not as prominent as decorin (Figure 3B). It
has been shown for fibroblasts that the nuclear shape can be
correlated with overall cell shape [52]. Decorin treatment resulted
in a complete rescue of the morphology index, whereas the
decorin core only partially rescued the phenotype. This suggests
that the extracellular dermatan sulfate proteoglycan decorin has
a different effect on the cells than the decorin protein core.
Only the Proteoglycan Decorin Treatment can Modulate
a2b1 Integrin Expression in Matrix-producing Dcn2/2
Fibroblasts
Decorin in the soluble form is known to bind to several cell
surface receptors [53]. Decorin can modulate a2b1 integrin
activity which requires the presence of the GAG chain [26,27].
a2b1 integrin is a collagen receptor and links the ECM to the
Figure 2. Expression of vimentin in 3D cultures of Dcn2/2 fibroblasts treated with either decorin or decorin core (core) at day 6.
Immunofluorescence staining of vimentin (A), decorin (C) and collagen type I (D) in m-slide VI, visualized by Alexa 488 conjugated secondary antibody
(green). Nuclei were stained with DAPI (blue). Images show merged z-axis layers of the complete 3D matrix. B: Quantification of vimentin
immunofluorescence signal in merged layers normalized to cell number (nuclei) per image. Data represent 5 independent experiments and are
expressed as mean 6 SD (for each condition and experiments, 15 images were evaluated; **, p,0.01). Bar = 100 mm.
doi:10.1371/journal.pone.0050809.g002
Figure 3. Analysis of nuclear morphology index. (A) Nuclei in 3D cultures of Dcn2/2 fibroblasts treated with either decorin or decorin core
(core) as well as 3D cultures of wild-type fibroblasts were stained with DAPI (blue) at day 6 in m-slide VI. (B) Length and width of nuclei were measured
using measureIT 5.1 (Olympus) and the length:width ratio was determined. The value of wild-type nuclei was set at 1 and corresponds to a more
circular shape of the nuclei. Student’s t test (unpaired) revealed significant differences between the Dcn2/2 fibroblasts compared to wild-type and
the decorin or decorin core treated samples. Data represent 3 independent experiments and are expressed as mean6 SD (for each condition, a total
of 50 nuclei were measured; *, p,0.05; **, p,0.01).
doi:10.1371/journal.pone.0050809.g003
Decorin Affects Vimentin
PLOS ONE | www.plosone.org 6 December 2012 | Volume 7 | Issue 12 | e50809
cytoskeleton [24,54]. To test whether decorin would affect b1
integrin expression, we used immunofluorescence and Western
blot analysis. Decorin was partially co-localized with b1 integrin in
the 3D Dcn2/2 cultures treated with decorin (Figure S4A) and
similarly in the 3D wild-type fibroblast cultures (Figure S4B).
Exposure to the decorin proteoglycan caused a marked suppres-
sion of b1 integrin immunoreactivity in Dcn2/2 fibroblast cultures
(Figure 4A,B). In contrast to the proteoglycan, the decorin core
had no effect (Figure 4B,C). Interestingly, also the decorin
treatment led to a significant reduction of b1 integrin in wild-
type fibroblasts after 6 days in culture (Figure S4C,D), however to
a lesser extent. We could also confirm, that the lack of decorin in
the dermis of Dcn2/2 mice leads to significantly more b1 integrin
protein compared to wild-type (Figure S5). For the b1 integrin we
could show that in Dcn2/2 fibroblasts decorin treatment reduced
mRNA expression (Figure 4D), which could be an explanation for
the reduction of the b1 integrin protein.
It is known that decorin as a proteoglycan can modulate a2b1
integrin, but not a1b1 activity [27], therefore, we examined the
expression of a2 subunits in Dcn2/2 fibroblasts. Decorin
treatment led to a significant reduction of a2 integrin indicating
that decorin affects the amount of a2b1 integrin in the Dcn2/2
cultures (Figure 5A,B). Interestingly, the decorin core altered also
the expression of the a2 integrin, which is in contrast to the b1
expression. Another b1 integrin partner is the a5 subunit. No
changes in a5 integrin and fibronectin, the respective ligand were
detected in Dcn2/23D fibroblasts cultures (Figure S6).
To determine whether the loss of decorin may influence the
amount of vimentin, via a2b1 integrin, fibroblasts deficient in
a2b1 [41] were cultured for 6 days in the presence of ascorbate-2-
phosphate followed by Western blot for vimentin. The quantifi-
cation and normalization to total protein amounts showed a,30%
reduction of vimentin in integrin a2-deficient fibroblasts compared
to the controls (Figure 5C). The reduction of vimentin was
confirmed in a2b1-null skin compared to wild-type skin by
immunofluorescence (data not shown).
Only the DS Proteoglycan Decorin, but not the Decorin
Core Increases the Pericellular H+ Concentration
Since decorin and decorin core had distinctly different effects on
b1 integrin we focused on the response of fibroblasts to post-
translational modifications of decorin. We showed previously that
DS decorin reduces the pericellular pH of melanoma cells [50]. In
addition to structure and constituents of the ECM, also the pH is
considered to have an impact on integrin activation [55].
Therefore, we measured the pericellular proton concentration in
Dcn2/2 fibroblasts seeded on collagen I. Treatment with decorin
and decorin core revealed different effects on the cell surface
proton concentration. DS decorin led to a significant increase in
the proton concentration, which could be due to the DS chain
whereas the decorin core resulted in an alkalinisation (Figure 6A).
The difference in the protein core of DS decorin and decorin core
is a His x6-Tag at the N-terminus of the decorin core which can be
protonated. These results suggest a different, pH-mediated impact
of the decorin proteoglycans and decorin core on matrix receptors
such as b1 integrins, indicates that the different forms of matrix
molecules might exert distinct and specific modulatory effects. To
demonstrate that DS decorin and the core differentially modulate
b1 integrin levels, we determined levels of active b1 integrin using
a specific antibody (clone 9EG7) that recognizes the active
conformation [56] in 6 day cultures of Dcn2/2 fibroblasts. The
Western blot for b1 integrin activity showed a clear difference
depending on the source of decorin (Figure 6B left panel). As
expected the core protein had no effect on levels of active b1
integrin, while DS decorin clearly increased active b1 integrin
(Figure 6B, right panel).
To demonstrate a mechanistic link between decorin, b1 integrin
and the vimentin IF in our 3D Dcn2/2 fibroblasts, cells were
cultured as described above, but in the presence of a b1 integrin
function-blocking antibody for the last 6 h [57]. In vitro it has
been shown that the phosphorylation required for assembly and
disassembly of vimentin is a fast and dynamic process leading to
changes in the IF system within 80 min [58]. Western blot analysis
for vimentin showed that decorin and decorin core had no effect
on the vimentin expression levels after blocking b1 integrin
(Figure 6C,D). Thus, we conclude that in Dcn2/2 fibroblasts,
addition of decorin stabilizes the vimentin IF and this, in turn,
might also affect a2b1 integrin expression during the synthesis of
a collagen-rich matrix (Figure 4D). Together we can show that
depending on the presence of the GAG chain the effects of the
decorin on a2b1 integrin levels and activity is different supporting
the importance of the proteoglycan decorin.
Vimentin mRNA Expression and Phosphorylation is
Increased by Decorin Core Treatment but not by Decorin
Treatment of Dcn2/2 fibroblasts with decorin or decorin core
for 6 days revealed that only decorin core was capable of
significantly increasing the vimentin mRNA levels (Figure 7A).
This result demonstrates once more that the molecular role of the
proteoglycan decorin is different from that of the decorin core.
The proteoglycan had no effect on the expression of vimentin
mRNA even though the amount of protein was significantly
increased at day 6 (cfr. Figure 1D) probably due to an
accumulation in decorin treated Dcn2/2 cultures. Surprisingly,
at day 3 in culture the proteoglycan decorin-treatment led to
a reduced amount of vimentin mRNA, indicating that the matrix
synthesised by the cells is affecting the function (Figure S2).
The phosphorylation of vimentin is necessary for the assembly
and disassembly of the existing filament system [58]. The
phosphorylation occurs at specific sites in the head-domain, for
example at Ser72. The Dcn2/2 fibroblasts were cultured in m-ibidi
slides for 6 days and stained for P-Ser72 and vimentin (Figure 7B).
The fluorescence signal was determined for P-Ser72 as well as for
vimentin and the quantification was normalised to the amount of
vimentin (Figure 7C). Interestingly, the amount of P-Ser72 was
increased in decorin core-treated cultures and not in Dcn2/2
fibroblasts.
To this end, Dcn2/2 fibroblasts were metabolically labelled for
12 h with a mixture of 35S-Methionine and 35S-Cysteine. The
incorporation of radioactive tracer was similar in decorin and
decorin core treated cultures. Afterwards, the cells were subjected
to immune precipitation at 4uC overnight followed by SDS-PAGE
and radio fluorography. The vimentin de novo synthesis was
increased by the decorin core compared to decorin-treated and
control samples (Figure 7F,G). These findings are supported by the
increase in mRNA and further corroborate our hypothesis that
only the proteoglycan decorin can stabilize the vimentin IF,
thereby supporting tissue integrity. In addition, a matrix lacking
the GAG chain of decorin leads to an increased turn-over of
vimentin and might therefore not be able to completely stabilize
the IF.
Discussion
In the present study, we provide evidence that the DS
proteoglycan decorin can modulate a2b1 integrin during matrix
synthesis and can influence cell morphology via stabilizing the
vimentin intermediate filament system. In vivo the loss of decorin
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in the dermis leads to a reduced amount of vimentin and to an
increase in b1 integrin. The link between a2b1 and vimentin was
confirmed by reduced vimentin levels in fibroblasts lacking a2b1
integrin. These findings could provide a reasonable explanation
for the delayed wound healing and atrophic scaring seen in Dcn2/
2 mice, the reduced tissue integrity and the EDS phenotype.
The dermis of Dcn2/2 mice is thinner, shows an altered
organization of fibrillar collagens and a delay in wound healing
[20,21]. To study the influence of decorin or its DS chain on cell
behavior we used a 3D cell culture model where Dcn2/2
fibroblasts produce their own collagen-rich matrix [22]. This is
a suitable model that resembles the in vivo situation [25]. These
cultures indeed represent the in vivo fibrillar collagen phenotype
of the Dcn2/2 mice [20] that can be rescued by addition of
decorin [22,23]. Interestingly, by addition or viral expression of
the decorin phenotype of the fibrillar collagens in cell culture is
similar to the dermatan C5-epimerase12/2 mice [19]. By
comparison of 2D gels of Dcn2/2 fibroblasts treated with decorin
or decorin core we detected changes in components of the
intracellular vimentin intermediate filament system.
Figure 4. Modulation of b1 integrin in 3D cultures of Dcn2/2 fibroblasts at day 6 by the DS proteoglycan decorin. (A)
Immunfluorescence staining of Dcn2/2 fibroblasts for b1 integrin in m-slide VI after treatment with either decorin or decorin core (core), visualized by
Cy3 conjugated secondary antibody (red). Nuclei were stained with DAPI (blue). Images show merged z-axis layers of the complete 3D matrix
(bar = 100 mm). (B) Representative Western blot of 3D cultures extracts for b1 integrin and the respective control GAPDH (lower panel). (C)
Quantification of b1 integrin signals shown in B in grey-scale values of Western blot signals and normalized to GAPDH as loading control. Student’s t
test (unpaired) revealed a significant difference for decorin treated cells compared to controls. Data represent 3 independent experiments and are
expressed as mean 6 SD (*, p,0.05). (D) Quantification of b1 integrin mRNA-levels by qRT-PCR. CT values were normalized to reference genes as
described in Materials & Methods. Data represent 3 independent experiments and are expressed as mean 6 SD (*, p,0.05).
doi:10.1371/journal.pone.0050809.g004
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Evaluation of the differentially expressed IF protein vimentin
showed that Dcn2/2 fibroblasts in vitro contain less vimentin as
compared to decorin-treated fibroblasts. This could be confirmed
in vivo as wild-type dermis contained more vimentin compared to
Dcn2/2 skin. Vim2/2 mice develop and behave normally [38].
However, these mutant mice display also delayed wound healing
[40] similarly to the Dcn2/2 mice [21]. Vimentin is required for
cell movement depending on the generation of significant traction
forces. The delay in wound healing of Vim2/2 mice could be
correlated with reduced tissue integrity and reduced migration of
the Vim2/2 fibroblasts [39]. Whether this also occurs in Dcn2/2
fibroblasts is difficult to assess, because, in our system the
fibroblasts do not migrate but instead they synthesis matrix.
Therefore, these similarities suggest that a decorin-containing
ECM stabilizes the vimentin IF system only if the DS chain is
present. Accordingly, EDS patients with partial lack of decorin DS
chain display altered wound healing with atrophic scarring [15].
In contrast to the DS proteoglycan decorin, the decorin protein
core only partially rescued the vimentin IF system. IF turnover
occurs along the length of the filaments, unlike that of
microfilaments or microtubules. Usually, there is only little IF
protein found in the soluble fraction [29]. We used m-ibidi slides to
avoid the problem of solubility and supported the results obtained
by immuno blotting that decorin evokes vimentin deposition. By
detecting a significant increase in vimentin mRNA, phosphoryla-
tion and de novo synthesis we demonstrate that the lack of the DS
chain of decorin increases the vimentin IF turnover during matrix
synthesis. In contrast to Dcn2/2 fibroblasts wild-type cells
synthesize significantly more vimentin mRNA (Figure S2). Hence,
the proteoglycan decorin stabilizes the vimentin IF. Furthermore,
the metabolic activity of Dcn2/2 cultures was increased upon
treatment with decorin or decorin core (data not shown). This
could be explained by increased protein synthesis. The decorin
core induces production, but is not able to properly deposit
vimentin, while decorin increases collagen I production and
deposition in the extracellular matrix [22].
Dcn2/2 mice show no obvious phenotype during their de-
velopment likely due to the functional compensation of biglycan
and its DS chains [59]. However, after wounding Dcn2/2 mice,
biglycan is not capable of compensating [21]. Cukiermann and
coworkers showed that cells synthesizing their own matrix are
closer to the in vivo situation compared to cells seeded in Matrigel
or collagen gels [60,61] or monolayer cultures [25].
Previously, it has been shown that the vimentin IF system
contributes to the localization and shape of the nuclei [36] and is
involved in the regulation of cell adhesion [32,33] by binding to
the cytoplasmic domain of a2b1 integrin. The loss of decorin
results in a more elongated shape of the nuclei, which is in line
with increased adhesion of Dcn2/2 fibroblasts [4]. Interestingly,
addition of decorin normalized the nuclear phenotype of the
Dcn2/2 cells to the level of wild-type fibroblasts whereas the core
protein itself only partially rescued the phenotype. Cell adhesion
was shown to regulate the cell shape, which resembles the shape of
the nucleus. In a 2D cell system the cell shape of fibroblasts seeded
on fibronectin depend on the organization of the actin cap [52].
The fibroblasts used in the present study synthesize a more
Figure 5. Influence of decorin on the a2 integrin subunit. (A) a2 integrin subunit expression in Dcn2/2 fibroblasts cultured for 6 days in the
presence of decorin or decorin core and the GAPDH control (lower panel). (B) Quantification of a2 integrin Western blot signals normalised to GAPDH
(3 independent experiments; *, p,0.05). (C) Analysis of a22/2 fibroblasts compared to wild-type by Western blot and the quantification of vimentin
normalised to total protein.
doi:10.1371/journal.pone.0050809.g005
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complex matrix [22,50] and therefore adhere to a mixture of
matrix molecules, which does not lead to changes in the actin
structures. Though, Dcn2/2 fibroblasts show increased adhesion
to collagen I and fibronectin substrates [4].
The link between the collagen-rich matrix and the cell’s interior
is provided by integrins containing the b1 subunit [54,62]. The
proteoglycan decorin can modulate a2b1, but not a1b1 integrins
on endothelial cells and increase cell adhesion [27]. Also, Dcn2/2
dermal fibroblasts express in vivo more b1 integrin compared to
control fibroblasts (Figure S3).
The ECM provides the dermis with tensile strength and
flexibility. The ECM molecule decorin is not only structural
scaffold binding to collagens but also can bind to cell surface
receptors or adhesion molecules. Decorin has previously been
shown to affect collagen phagocytosis by inhibiting the binding of
fibrillar collagen to a2b1 integrin in gingival fibroblasts. In
conditions requiring matrix synthesis like in wound healing
decorin might thereby help to build up the collagen network
[63]. In line with this notion we showed that Dcn2/2 fibroblasts
synthesize and deposit more collagen I when treated with decorin
[22]. In the tissue-forming phase of wound healing, the fibroblasts
synthesize collagen and decorin might prevent the phagocytosis of
collagen to support matrix synthesis. Our study shows that the
addition of exogenous decorin proteoglycan to Dcn2/2 fibroblasts
during collagen/matrix synthesis and deposition reduces the
amount of both the b1 integrin mRNA, possibly due to
sequestering TGF- b [64,14], and a2b1 protein. The reduction
of a2b1 integrin by decorin or decorin core could indirectly
influence the adhesion of the fibroblasts in their own collagen-rich
matrix visible by the nuclear morphology. Nieminen and co-
workers showed that the reorganization of vimentin IF in blood
cells reflects the role of IF in forming anchoring structures for
adhesion molecules on the cell surface [65]. In Dcn2/2 mice
during DTH, the adhesion of leukocytes to the endothelium is
increased but the transmigration is decreased [12]. These results
and the interaction of vimentin with the a2b1 cytoplasmic tail [34]
support our hypothesis, that the decorin is necessary to stabilize
the vimentin IF via a2b1 integrin. Cell adhesion depends on the
activity state of integrins, which can assume either of three
different activity states: high, low and intermediate affinity
conformation [66]. Furthermore, the activity state of integrins
depends on the pH. An acidic extracellular pH leads to an
increased avidity [55]. In the present study, only proteoglycan
decorin treatment leads to a weak acidification of the pericelluar
pH. In contrast, the decorin core leads to an alkalinization, and
therefore is not influencing b1 integrin activity in a way that would
strengthen adhesion. However, DS proteoglycan decorin influ-
enced the activity of b1 integrin in our 3D model and also affects
in vitro the activity state of a2b1 integrin [27]. This is in line with
previous publications demonstrating that the GAG chain is
required for decorin-dependent b1 integrin modulation [26,27].
Interestingly, the DS proteoglycan decorin inhibits melanoma cell
Figure 6. Cell surface proton concentration and activity of b1 integrin in Dcn2/2 fibroblasts is altered by decorin treatment. (A)
Determination of the proton concentration on the cell surface after treatment with 0.3125 mg/ml decorin and decorin core (core). Dcn2/2 fibroblasts
were cultured over night on collagen type I coated wells as described in Materials and Methods (Decorin n = 22 cells; core n = 33 cells; *, p,0.05,
n.s. = not significant). (B) Western blot with b1 integrin antibody 9EG7 that recognizes the active form of b1 integrin of Dcn2/2 fibroblasts cultured for
6 days in the presence of ascorbate-2-phosphate and decorin or decorin core (core) (upper panel). The quantification of the Western blot for active b1
integrin is normalised to total protein stain (lower blot) (3 independent experiments; *, p,0.05, paired t’test). (C) Western blot for vimentin of Dcn2/2
fibroblasts cultured for 6 days in the presence of ascorbate-2-phosphate and decorin or decorin core (core). 6 h prior to harvesting the cells were
treated with a b1 integrin blocking antibody and analysed for vimentin (upper panel). The loading control GAPDH is shown in the lower panel. (D)
Quantification of the Western blot for vimentin normalised to GAPDH. Data represent 3 independent experiments and are expressed as mean 6 SD.
doi:10.1371/journal.pone.0050809.g006
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migration by reversibly acidifying the cell surface pH to an
intermediate value of 7.1 [50], where migration reaches its
maximum [67]. In the present 3D cell culture model that
resembles a wound healing model, decorin expression in wild-
type fibroblasts is increased at day 4–6 (data not shown). This
could alter both the amount and the avidity of b1 integrin and
thereby influence cell/matrix interaction in wild-type, but not in
Dcn2/2 fibroblasts. Decorin from skin fibroblasts contains GAGs
of complex, different sulfated DS structures [50]. As phosphory-
lation of vimentin is increased in decorin core-treated fibroblasts,
we hypothesize elevated P-vimentin levels could contribute to
a reduced mechanical stability of the matrices. This can be linked
to the cutis laxa of EDS patients where decorin is synthesized
partially without a GAG chain [15].
In conclusion, we demonstrate for the first time that DS of
decorin is required to stabilize the vimentin IF system which is
linked to a2b1 integrin. This is in line with the finding that Dcn2/
2 dermis contains less vimentin compared to wild-type. Further-
more, the lack of decorin leads to an increase in dermal b1 integrin
protein. In agreement with these findings, exogenous decorin
reduces the amount of b1 integrin at both the mRNA and protein
levels in Dcn2/2 and wild-type fibroblasts and these effects might
influence adhesion and cell shape. The influence of DS decorin on
vimentin offers a novel explanation for the reported delay in
wound healing of Dcn2/2 mice and for the cutis laxa of EDS
patients with defects in the biosynthesis of decorin.
Supporting Information
Figure S1 Influence of decorin and decorin protein core
on protein expression by Dcn2/2 fibroblasts analyzed.
2D Gel electrophoresis of Dcn2/2 fibroblasts treated for 2 days
with ascorbate-2-phosphate and decorin, decorin core and the
respective control. Cells were harvested with a buffer containing
Figure 7. Analysis of vimentin synthesis and degradation in 3D cultures of Dcn2/2 fibroblasts at day 6 treated with either decorin
or decorin core (core). (A) Quantification of vimentin mRNA expression with qRT-PCR (n = 3 independent experiments; *, p,0.05). CT values were
normalized to reference genes. (B) Immuno fluorescence staining for phospho-vimentin P-Ser72 in m-slide VI visualized by Alexa 488 conjugated
secondary antibody (green). Nuclei were stained with DAPI (blue). Images show merged of z-axis layers of the complete 3D matrix (bar = 100 mm). (C)
Quantification of phospho-vimentin immunofluorescence signal in merged layers normalized to cell number (nuclei) per image and related to total
amount of vimentin (Fig. 5) (n = 3 independent experiments; for each condition, 15 images were measured). Student’s t test (unpaired) revealed
differences between the core-treated and the control cells. Data are expressed as mean 6 SD (n = 3 independent experiments; *, p,0.05). (D)
Vimentin immunoprecipitation followed by a Western blot for total sulfation (P-Ser/Thr/Tyr). Coomassie gel for total protein is shown in the lower
panel. (E) Quantification of P-vimentin normalized to total protein amounts. Data represent 3 independent experiments and are expressed as mean6
SD. (F) Dcn2/23D cultures were metabolically labeled for 12 h with 100 mCi/ml 35S-Methionine/35S-Cysteine followed by fluorography.
Immunoprecipitation with vimentin antibody showed the de novo synthesis is increased by decorin protein core treatment. (G) Quantification of
vimentin de novo synthesis. Data are expressed as mean 6 SD (n = 3 independent experiments; *, p,0.05).
doi:10.1371/journal.pone.0050809.g007
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8 M urea, 2% (w/v) CHAPS, 20 mM DTT and subjected to
isoelectric focusing between pH 3 and 10 according to manufac-
tures’ instructions (ZOOM IPGRunner Kit, Invitrogen). (A)
Representative 2D gel of the control after colloidal Coomassie
staining. Marked square is magnified for control cells (B), decorin
(C) and decorin core (D) treated cells. Gel spots (*) were analyzed
by mass spectrometry (Center for Molecular Medicine, Cologne)
and identified as vimentin.
(TIF)
Figure S2 Vimentin mRNA expression in wild-type and
Dcn2/2 fibroblasts measured at day 3 in culture. Dcn2/2
fibroblasts were treated with decorin or decorin core or left
untreated. Interestingly, wild-type fibroblasts express significantly
more vimentin mRNA compared to Dcn2/2. This is supporting
the reduced amount of vimentin protein found in the dermis of
Dcn2/2 mice compared to wild-type. Furthermore, the core
protein is not affecting the expression of vimentin in a 2D culture.
Surprisingly the dermatan sulphate proteoglycan decorin signifi-
cantly reduces the amount of vimentin mRNA at day 3 in culture
(n = 3 independent experiments).
(TIF)
Figure S3 Analysis of actin and fibrillar structures on
the Dcn2/2 fibroblast surface after treatment with
decorin or decorin core (core). (A) Quantification of b-actin
mRNA-expression with qRT-PCR (n= 3 independent experi-
ments). CT values were normalized to reference genes as described
in Materials & Methods. Students’ t-test (unpaired) showed no
significant difference between the samples. (B) Immunofluores-
cence staining for F-actin with phalloidin coupled to Alexa 488
(green) in m-slide VI. Nuclei were localized with DAPI (blue).
Images show a merge of z-axis layers of the complete 3D matrix.
(C) Quantification of F-actin immunofluorescence signal in
merged layers normalized to the number of cells (nuclei) per
image. Students’ t-test (unpaired) showed no significant differences
between the samples. Data are expressed as mean 6 SD (n= 3
independent experiments; for each condition 15 images were
measured). (D) Atomic force microscopy (AFM) of the cortical
actin microfilament network in Dcn2/2 fibroblasts at day 2.
(TIF)
Figure S4 Partial colocalization of decorin and b1
integrin in 3D cultures of Dcn2/2 fibroblasts at day 6
treated with decorin and wild-type fibroblasts. (A) Double
immunofluorescence staining for b1 integrin (red) and decorin
(green) in m-slide VI of Dcn2/2 fibroblasts. Colocalizations of
decorin and b1 integrin (yellow) are indicated by white arrow-
heads. (B) Wild-type fibroblasts fluorescence staining for b1
integrin (red) and decorin (green) in m-slide VI. Nuclei were
localized with DAPI (blue). Images show a merge of z-axis layers of
the complete 3D matrix (digital magnification). (C) The represen-
tative Western blot for b1 integrin in the analyzed 3D wild-type
fibroblast cultures and the respective control GAPDH (lower
panel). (D) For quantification of b1 integrin expression grey-scale
values of Western blot signal were normalized to GAPDH as
loading control. Student’s t-test (unpaired) revealed a significant
difference for decorin treated cells compared to the control. Data
are expressed as mean 6 SD (n= 3 independent experiments; *,
p,0.05).
(TIF)
Figure S5 Detection of b1 integrin in vivo in Dcn2/2 and
wild-type newborn mouse dermis. (A) Western blot for b1
integrin with dermis extracts of wild-type and Dcn2/2mice (upper
panel). Coomassie gel was used as loading control (lower panel).
(B) Quantification of Western blot, b1 integrin signal was
normalized to the Coomassie gel staining (n = 3 independent
experiments; *, p,0.05).
(TIF)
Figure S6 Detection of fibronectin and a5 integrin in
Dcn2/2 fibroblasts. (A) Western blot for a5 integrin (upper
panel) and fibronectin (middle panel) of Dcn2/2 fibroblasts
cultured for 6 days in the presence of ascorbate-2-phosphate and
decorin or decorin core (core). The loading control GAPDH is
shown in the lower panel. (B) Quantification of the Western blot
for a5 integrin normalized to GAPDH (n=3 independent
experiments). (C) Quantification of the Western blot for
fibronectin normalized to GAPDH (n= 3 independent experi-
ments).
(TIF)
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